Le Lézard
Classified in: Health
Subjects: TDS, FDA

Convexity Scientific Receives FDA Clearance For Its FLYPtm Nebulizer, Unveils The New Device At Medtrade Spring


LAS VEGAS, March 27, 2018 /PRNewswire/ -- Following its FDA clearance in May 2017, today, Convexity Scientific (Booth #777), a medtech company committed to innovative design and distribution strategies, unveiled its FLYPtm nebulizer, a game-changing handheld nebulizer that is poised to disrupt how physicians treat pulmonary conditions such as asthma and COPD.

"FLYPtm is literally breathing new life into the nebulizer market by offering physicians a solution that puts convenience, portability and busy lifestyles at the forefront of how they treat patients with debilitating respiratory conditions, without compromising efficacy or patient outcomes," said Jim Daniels, CEO of Convexity Scientific. He added, "We founded Convexity to conceive of and develop next generation medical devices with patients' lifestyles in mind and we look forward to sharing our first innovation, the FLYPtm nebulizer, with thousands of top healthcare providers and industry leaders at Medtrade Spring."

Smaller and lighter than a smartphone, FLYPtm is a pocket-portable and virtually silent nebulizer that can be used at home or in a healthcare facility. The "all-in-one" design means that there are no tubes or control units?users just fill, click, breathe.

"For patients suffering from asthma, COPD and other lung-related diseases, FLYPtm offers a convenient and effective alternative to preventing and managing flare-ups," said Dr. Ralph Finger, Co-Founder and Chairman of Convexity Scientific and inventor of FLYP. "For years, the patient has been asked to fit their life to their nebulizer. Now with FLYP, there's a nebulizer that fits into their life."

With HypersoniQtm technology, FLYPtm utilizes an internal disk that vibrates at an ultrasonic speed. When medication passes through the disk's holes, it produces an inhalable aerosol mist, delivering medication deep into the lungs where it is most effective. Because the disk vibrates 110,000 times per second, the time it takes to dispense the medication is significantly shortened to about seven minutes for most medications.

Powered by a USB rechargeable lithium-ion battery that lasts 10 treatments between recharging, FLYPtm allows patients to stop wasting time and money on disposable batteries.  FLYPtm optimizes portability and usability, which may result in increased compliance to recommended treatment schedules.

FLYPtm is available at flypnebulizer.com for $249.99.

About Convexity Scientific 
Convexity Scientific Inc. is a Fairfield, Connecticut-based medical technology company that is developing the next generation of devices with patients' lifestyles in mind. The company's first medical device, the FLYPtm handheld nebulizer for respiratory diseases, demonstrates Convexity's commitment to transforming medical devices with radical reinventions. FLYP is FDA cleared to treat patients ages 13 and up. For more, go to http://www.flypnebulizer.com.

Press Contacts:
Will Obre
Kwittken
[email protected] 
646 747 7154

SOURCE Convexity Scientific


These press releases may also interest you

at 22:29
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 22:03
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

at 21:30
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...



News published on and distributed by: